Abiopharma

🔍 HENNING THOMAS EDWARD (Executive)

Company: NELNET INC (NNI)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-15 | Code: H | shares_owned_after: 11,058.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: IRA | shares_owned_after: 13.00 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: Spouse IRA | shares_owned_after: 8.00 | Footnotes: F2
• Acquired 1,738 shares of Phantom Stock (Derivative)
  Date: 2026-06-15 | Code: A | equity_swap_involved: false | shares_owned_after: 59,312.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4, F5

Footnotes:

• F1: Represents shares held in the reporting person's IRA for which acquisition records are no longer available, which were inadvertently omitted from prior Section 16 filings.
• F2: Represents shares held in the IRA of the reporting person's spouse for which acquisition records are no longer available, which were inadvertently omitted from prior Section 16 filings.
• F3: 1-for-1.
• F4: The shares of phantom stock were granted pursuant to the issuer's Directors Stock Compensation Plan. They will become payable in shares of Class A Common Stock promptly after the time of termination of the reporting person's service as a member of the issuer's Board of Directors. The shares will be payable in a lump sum promptly after the time of termination of the reporting person's service as a member of the issuer's Board, or in up to five annual installments, commencing promptly after the time of termination of the reporting person's service on the issuer's Board, as elected by the reporting person.
• F5: Includes a total of 574 shares acquired since June 18, 2025 pursuant to the dividend reinvestment feature of the issuer's Directors Stock Compensation Plan.